Abstract

Cannabidiol (CBD) is all the rage in the wellness industry, but most large drugmakers are not interested in a molecule they can’t patent. A few start-ups and niche firms, however, are developing sm...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call